PubRank

D C Shugars

Author PubWeight™ 25.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci U S A 1994 8.48
2 Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J Virol 1998 4.48
3 Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997 2.41
4 HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS 2001 2.08
5 Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J Virol 1993 1.77
6 Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol 2000 1.60
7 Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity. J Virol 2005 1.01
8 Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. J Virol 2001 0.93
9 Limits on oral transmission of HIV-1. Lancet 2000 0.89
10 Cobalamin inhibition of HIV-1 integrase and integration of HIV-1 DNA into cellular DNA. Biochem Biophys Res Commun 1998 0.82
11 Immunologic and viral markers of HIV-1 disease progression: implications for dentistry. J Am Dent Assoc 1999 0.80
12 Inhibition of productive human immunodeficiency virus-1 infection by cobalamins. Blood 1995 0.77